American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 719-723, May 2008

Efficacy and Safety of Fondaparinux and Enoxaparin for Acute Coronary Syndromes in CKD

  • Donald F. Brophy, PharmD, MSc, BCPS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Donald F. Brophy, PharmD, MSc, FCCP, BCPS, Associate Professor of Pharmacy and Internal Medicine (Nephrology), Director, Coagulation Special Studies Laboratory, Department of Pharmacy, Virginia Commonwealth University/Medical College of Virginia Campus, PO Box 980533, Richmond, VA 23298-0533.

Virginia Commonwealth University, Richmond, Virginia

published online 03 April 2008.

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Originally published online as doi:10.1053/j.ajkd.2008.02.002 on March 31, 2008.

PII: S0272-6386(08)00165-0

doi:10.1053/j.ajkd.2008.02.002

American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 719-723, May 2008

Article Tools